(a) End-stage renal disease

Characteristicsa	Total		Screened positive		Screened negative		Verified ESRD		Randomly selected subcohortb
	n = 43 433		n = 822		n = 42 611		n = 620		n = 2415
Demographics
Median age at enrollment (years, IQR)	39	(33, 46)	42	(33, 49)	39	(33, 46)	41	(35, 48)	39	(33, 45)
Male sex (n, %)	34 611	80%	567	69%	34 044	80%	435	70%	1861	77%
Race and ethnicity (n, %)
Non-Hispanic Black	14 720	34%	652	79%	14 068	33%	519	84%	996	41%
Non-Hispanic White	18 068	42%	93	11%	17 975	42%	51	8%	963	40%
Hispanic	5252	12%	55	7%	5197	12%	34	5%	183	8%
Other/unknown	5393	12%	22	3%	5371	13%	16	3%	276	11%
HIV transmission risk (n, %)c
Men who have sex with men	20 006	46%	201	24%	19 805	46%	156	25%	1078	45%
Injection drug use	6278	14%	188	23%	6090	14%	142	23%	410	17%
Heterosexual contact	10 576	24%	337	41%	10 239	24%	250	40%	715	30%
Other/unknown	6573	15%	96	12%	6477	15%	72	12%	215	9%
Hepatitis B/C coinfection
Hepatitis C infection (n, %)	8222	19%	313	38%	7909	19%	238	38%	576	24%
Hepatitis B infection (n, %)	3938	9%	96	12%	3842	9%	73	12%	234	10%